Skip to content

Evaluation of the Impact of the SMART ANGEL ™ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery

Evaluation of the Impact of the SMART ANGEL ™ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery: Randomized Controlled Open-label Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04068584
Acronym
SMART ANGEL 2
Enrollment
1260
Registered
2019-08-28
Start date
2020-02-03
Completion date
2024-11-18
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ambulatory Surgery

Brief summary

The investigators hypothesize that by monitoring and analyzing physiological parameters (heart rate, blood pressure, saturation) and well-being (pain, nausea, vomiting, comfort) the SMART ANGEL ™ device improves the quality of care after major or intermediate outpatient surgery. This active surveillance will result in a decrease in the rate of unplanned recourse (hospitalization, consultation, telephone call).

Interventions

OTHERSmart Angel

Patient issued with a tablet with the Smart Angel application to monitor clinical signs and symptoms

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER
Evolucare Technologies
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan * The patient is undergoing ambulatory surgery for: * in orthopedics: shoulder (arthroscopy, abutment, prosthesis), hip (prosthesis, arthrolysis), knee (osteotomy, ligamentoplasty), ankle (prosthesis, ligamentoplasty) foot (hallux valgus); removal of major or multi-site equipment; * digestive (cholecystectomy, hernia repair, partial gastrectomy, colectomy, cleaning); * in gynecology (hysterectomy, oophorectomy, mastectomy, quadrantectomy, dissection, cystoplasty, sphincter); * in urology (total or partial resection of the prostate); * ENT (thyroidectomy, tonsillectomy); * Neurosurgery (herniated disc); * Vascular (stripping varix, creating fistula). * The patient has sufficient intellectual and cognitive capacity to use the devices * The patient must pass the test performed during the anesthesia consultation, namely: * open and connect the tablet, * activate the measurement of the blood pressure and the measurement of the oxygen saturation, * be connected to a 4G network

Exclusion criteria

* The subject is in a period of exclusion determined by a previous study * The subject refuses to sign the consent * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship * The patient is pregnant * The patient is undergoing emergency or minor surgery * Patient has a psychological class ASA 5 * Patient is non-eligible for ambulatory surgery for medical reasons (decompensated medical pathology) or social reasons according to the criteria defined by the société française anesthésie réanimation. Person lives alone or has a geographical distance from a hospital center\> 30 km (or\> 45 min by car). * Patient who doesn't classify for ambulatory surgery at time of discharge

Design outcomes

Primary

MeasureTime frameDescription
Non-scheduled hospitalization rates between groupsDay 5%
Number of non-scheduled consultations between groupsDay 5%
Rates of calls with nurses between groupsDay 5%
Rates of calls with doctors between groupsDay 5%
Rates of unplanned prescriptions between groupsDay 5%
Rates of unplanned exams between groupsDay 5%

Secondary

MeasureTime frameDescription
Rate of complications between groupsDay 1% patients reported any of: nausea, vomiting, constipation, allergy, shivering, insomnia, pain, fever, sore throat, lower back pain, headache, hypotension, bradycardia, hallucination, fainting, reopening of the incision, repeated surgery, abscess, bleeding, or bruising
Rate of readmission between groupsMonth 1Yes/No
Date of return to work or other activity1 MonthDd/mm/yyyy
Patient satisfactionDay 6Visual Analog Scale 0-10
Patient quality of life1 monthEQ-5D-5L questionnaire taken over the phone
Difficulties in using the deviceDay 5In-house developed usage questionnaire assessing measurement difficulties, saving errors, connection problems, problem contacting care staff
Requirement of external help in using the deviceDay 5Description of person sought for advice
Times spent on deviceDay 5Hours; automatically calculated by device for time used for manipulation and time for navigation
Technical errors arisingDay 5Automatically calculated by device

Countries

France

Contacts

STUDY_DIRECTORChristhophe Boisson

CHU Nimes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026